EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial

NARecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 19, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions
Major Depression With Comorbid Anxiety SymptomsMajor Depressive Disorder (MDD)
Interventions
DEVICE

Active swLORETA Z-score Neurofeedback

Participants receive 10 sessions (25 minutes each, twice per week for 5 weeks) of EEG-based neurofeedback using the NeuroGuide® software and a 24-channel EEG recording system (eego™, ANT Neuro). The neurofeedback protocol is based on real-time swLORETA Z-score training targeting brain regions involved in emotion regulation. Feedback is provided via gamified visual displays when EEG activity moves toward normative patterns. This is an operant conditioning-based protocol designed to enhance emotional self-regulation.

DEVICE

Yoked-sham swLORETA Z-score Neurofeedback

"Participants receive 10 sessions identical in appearance and duration to the active neurofeedback condition. However, the feedback provided is not based on their own EEG activity. Instead, it is pre-recorded data from a matched participant in the active group (yoked design), ensuring no real-time neurophysiological modulation occurs. The same EEG equipment and visual feedback interface are used to maintain blinding."

Trial Locations (1)

08208

RECRUITING

Corporació Sanitària Parc Taulí de Sabadell, Sabadell

Sponsors
All Listed Sponsors
collaborator

Horizon 2020 - European Commission

OTHER

lead

Corporacion Parc Tauli

OTHER